Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/27/1996 | WO1996041874A1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
12/27/1996 | WO1996041873A1 Dry powder formulations of polynucleotide complexes |
12/27/1996 | WO1996041872A1 Device 'biotron tszyan-2' for transmitting a natural information supply to a biological object |
12/27/1996 | WO1996041869A1 Cis-9,10-octadecenoamidase |
12/27/1996 | WO1996041868A2 Prothrombin derivatives |
12/27/1996 | WO1996041865A1 Rapamcycin-based regulation of biological events |
12/27/1996 | WO1996041811A1 Magnetic pigment |
12/27/1996 | WO1996041810A1 Method and apparatus for dna extraction |
12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | WO1996041607A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
12/27/1996 | WO1996041606A2 Improved pharmaceutical compositions for gene therapy |
12/27/1996 | WO1996041528A1 Use of saponin for pathogen control |
12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
12/27/1996 | WO1996037605A3 Anti sense oligonucleotides for blocking ige receptor synthesis |
12/27/1996 | WO1996036717A3 Dna sequences encoding a lycopene cyclase, antisense sequences derived therefrom and their use for the modification of carotenoids levels in plants |
12/27/1996 | WO1996035784A3 Chromatin-regulator genes |
12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
12/27/1996 | WO1996029431A3 Dna diagnostics based on mass spectrometry |
12/27/1996 | WO1996021731A3 Stabilized external guide sequences |
12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
12/27/1996 | EP0750043A1 Exopolysaccharides-producing lactic acid bacteria |
12/27/1996 | EP0750042A1 Exopolysaccarides-producing lactic acid bacteria |
12/27/1996 | EP0750041A2 HIV-2 nucleotide sequences |
12/27/1996 | EP0750040A2 Macrophage stimulating protein variant and method for producing the same |
12/27/1996 | EP0750039A1 Immunoregulatory protein LST-1 |
12/27/1996 | EP0750038A2 A mutant gene causing a defect in mitochondrial recombination and a method for its detection |
12/27/1996 | EP0749981A1 Monoclonal antibody |
12/27/1996 | EP0749980A1 Novel human ciliary neurotrophic factor |
12/27/1996 | EP0749581A1 Binding assay using binding agents with tail groups |
12/27/1996 | EP0749498A1 Combined use of genetic markers for the diagnosis of alzheimer's disease, diagnostic kit and method |
12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
12/27/1996 | EP0749492A1 Humanized milk |
12/27/1996 | EP0749491A1 Enhanced expression in a plant plastid |
12/27/1996 | EP0749490A1 EXPRESSION OF $i(BACILLUS THURINGIENSIS CRY) PROTEINS IN PLANT PLASTIDS |
12/27/1996 | EP0749489A1 Combined use of two expression cassettes for the production of a useful protein |
12/27/1996 | EP0749488A1 Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders |
12/27/1996 | EP0749487A1 Cell surface protein and effector cell bonding reagent |
12/27/1996 | EP0749486A1 Diagnostic skin test for tuberculosis |
12/27/1996 | EP0749485A1 ANTIMICROBIAL PROTEINS FROM $i(ARALIA) AND $i(IMPATIENS) |
12/27/1996 | EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION |
12/27/1996 | EP0749481A1 Humanized monoclonal antibodies against human interleukin-4 |
12/27/1996 | EP0749480A1 Novel forms of t cells costimulatory molecules and uses therefor |
12/27/1996 | EP0749479A1 Novel thiol protease inhibitor |
12/27/1996 | EP0749478A1 Yeast strains and modified albumins |
12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
12/27/1996 | EP0749476A1 Mediators of chronic allograft rejection |
12/27/1996 | EP0749475A1 Use of the cytokine ip-10 as an anti-tumor agent |
12/27/1996 | EP0749472A1 Extracorporeal cell culture and transplantation kits |
12/27/1996 | EP0749445A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
12/27/1996 | EP0749443A1 Fk-506 cytosolic binding protein |
12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
12/27/1996 | EP0749441A1 Expression and purification of cloned human alpha-fetoprotein |
12/27/1996 | EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS |
12/27/1996 | EP0749320A1 Fibrin-specific antibody for use as an antithrombotic agent |
12/27/1996 | EP0749319A1 Immortalized cells and uses therefor |
12/27/1996 | EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
12/27/1996 | EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
12/27/1996 | EP0684952A4 Method for the immobilization of nucleic acid molecules. |
12/27/1996 | EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
12/27/1996 | CA2607563A1 Magnetic particles with a glass surface and their use |
12/27/1996 | CA2605671A1 Magnetic particles with a glass surface and their use |
12/27/1996 | CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | CA2230815A1 Device "biotron tszyan-2" for transmitting a natural information supply to a biological object |
12/27/1996 | CA2226405A1 Nanofabricated separation matrix for analysis of biopolymers and methods of making and using same |
12/27/1996 | CA2224634A1 Prothrombin derivatives |
12/27/1996 | CA2224567A1 Process for identifying secretory genes from helicobacter pylori |
12/27/1996 | CA2224394A1 Dna markers for pig litter size |
12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | CA2224156A1 Dry powder formulations of polynucleotide complexes |
12/27/1996 | CA2224146A1 Improved pharmaceutical compositions for gene therapy |
12/27/1996 | CA2224089A1 Expression of human inducible nitric oxide synthase |
12/27/1996 | CA2224073A1 Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120 |
12/27/1996 | CA2223896A1 Method and apparatus for dna extraction |
12/27/1996 | CA2222628A1 Microelectrophoresis chip for moving and separating nucleic acids and other charged molecules |
12/27/1996 | CA2222208A1 P-53 binding protein called mdmx and encoding sequences for said protein |
12/27/1996 | CA2221311A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1996 | CA2221029A1 Malarial pre-erythrocytic stage polypeptide molecules |
12/27/1996 | CA2219080A1 Rapamycin-based regulation of biological events |
12/27/1996 | CA2196973A1 Use of a saponin for pathogen control |
12/27/1996 | CA2161391A1 Stable transformation |
12/25/1996 | CN1138865A Peptides and methods against psoriasis |
12/25/1996 | CN1138864A New compsn. of glycoprotein isoforms having follicle stimulating |
12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
12/25/1996 | CN1138632A Expression and secretion of hereologous proteins by yarrowia lipolytica transformants |
12/25/1996 | CN1138631A 5-keto glyconic acid produced from microbe |
12/24/1996 | US5587478 Sapphyrin multimers |
12/24/1996 | US5587470 3-deazapurines |
12/24/1996 | US5587469 Oligonucleotides containing N-2 substituted purines |
12/24/1996 | US5587468 High affinity nucleic acid ligands to HIV integrase |
12/24/1996 | US5587462 Corticotropin releasing factor; stimulates the secretion and biosynthesis of acth |
12/24/1996 | US5587460 Controller of cell differentiation; immunology |
12/24/1996 | US5587361 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/24/1996 | US5587359 Human derived glycoprotein, biologically active factor which includes glycoprotein and pharmaceutical product |
12/24/1996 | US5587308 Modified adeno-associated virus vector capable of expression from a novel promoter |
12/24/1996 | US5587307 FemA gene of staphylococcus epidermidis, femA protein, and vectors and microorganisms comprising the femA gene |
12/24/1996 | US5587306 Dna sequences |
12/24/1996 | US5587305 Pasteurella haemolytica transformants |